World Journal of Cardiovascular Surgery

Volume 6, Issue 4 (April 2016)

ISSN Print: 2164-3202   ISSN Online: 2164-3210

Google-based Impact Factor: 0.10  Citations  

A Five-Year Experience of Sparing Treatment of Descending Aortic Atherosclerotic Aneurysms

HTML  XML Download Download as PDF (Size: 308KB)  PP. 47-54  
DOI: 10.4236/wjcs.2016.64009    2,180 Downloads   3,011 Views  Citations

ABSTRACT

A growing number of specialists are now beginning to ascertain that treatment of individuals with descending aortic atherosclerotic aneurysms must be provided by cardiologists on a scheduled basis. Surgery is feasible when there is a risk of aneurysm rupture. It requires for the development of conservative treatments and elaboration of indications for surgery. A total of 97 patients with thoracic aortic atherosclerotic aneurysms (TAAA) and abdominal aortic aneurysms (AAA) have been examined over a 5-year period. They received multifaceted anti-inflammatory medical treatment to strengthen the aortic wall and control its possible expansion. Operative treatment was offered only if there was a risk of aneurysm rupture. One of the principal factors adversely affecting mortality is the presence of co-morbidities requiring permanent medical corrective treatment irrespective of surgical or medical treatment provided. It is also important to outline the indications for surgery based on multifactorial pathogenetic manifestations. Treatment aiming at the reversal of ethiopathogenic mechanisms of disease progression contributes to a significant longer survival in DAA patients.

Share and Cite:

Krylov, V. , Mrochek, A. , Gayduk, V. , Reut, L. , Smaliakou, A. , Mankevich, N. and Pizhik, R. (2016) A Five-Year Experience of Sparing Treatment of Descending Aortic Atherosclerotic Aneurysms. World Journal of Cardiovascular Surgery, 6, 47-54. doi: 10.4236/wjcs.2016.64009.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.